Dynavax Technologies Corp (DVAX)
11.86
+0.07
(+0.59%)
USD |
NASDAQ |
Nov 05, 10:17
Dynavax Technologies Market Cap: 1.554B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.545B |
| November 01, 2024 | 1.544B |
| October 31, 2024 | 1.553B |
| October 30, 2024 | 1.580B |
| October 29, 2024 | 1.548B |
| October 28, 2024 | 1.493B |
| October 25, 2024 | 1.403B |
| October 24, 2024 | 1.411B |
| October 23, 2024 | 1.424B |
| October 22, 2024 | 1.440B |
| October 21, 2024 | 1.439B |
| October 18, 2024 | 1.435B |
| October 17, 2024 | 1.431B |
| October 16, 2024 | 1.445B |
| October 15, 2024 | 1.410B |
| October 14, 2024 | 1.371B |
| October 11, 2024 | 1.367B |
| October 10, 2024 | 1.347B |
| October 09, 2024 | 1.388B |
| October 08, 2024 | 1.393B |
| October 07, 2024 | 1.411B |
| October 04, 2024 | 1.444B |
| October 03, 2024 | 1.466B |
| October 02, 2024 | 1.487B |
| October 01, 2024 | 1.481B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.460B |
| September 27, 2024 | 1.441B |
| September 26, 2024 | 1.422B |
| September 25, 2024 | 1.411B |
| September 24, 2024 | 1.424B |
| September 23, 2024 | 1.456B |
| September 20, 2024 | 1.487B |
| September 19, 2024 | 1.507B |
| September 18, 2024 | 1.469B |
| September 17, 2024 | 1.476B |
| September 16, 2024 | 1.461B |
| September 13, 2024 | 1.464B |
| September 12, 2024 | 1.438B |
| September 11, 2024 | 1.430B |
| September 10, 2024 | 1.466B |
| September 09, 2024 | 1.424B |
| September 06, 2024 | 1.445B |
| September 05, 2024 | 1.422B |
| September 04, 2024 | 1.423B |
| September 03, 2024 | 1.426B |
| August 30, 2024 | 1.470B |
| August 29, 2024 | 1.476B |
| August 28, 2024 | 1.443B |
| August 27, 2024 | 1.469B |
| August 26, 2024 | 1.494B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
195.65M
Minimum
Mar 16 2020
2.512B
Maximum
Nov 03 2021
1.280B
Average
1.422B
Median
Sep 05 2024
Market Cap Benchmarks
| Biogen Inc | 25.50B |
| Repligen Corp | 7.893B |
| West Pharmaceutical Services Inc | 23.52B |
| XOMA Royalty Corp | 353.71M |
| Xencor Inc | 1.314B |
Market Cap Related Metrics
| PE Ratio | 107.82 |
| PS Ratio | 6.748 |
| Price to Book Value | 2.418 |
| Price to Free Cash Flow | 47.69 |
| Price | 11.86 |
| Earnings Yield | 0.93% |
| Normalized PE Ratio | 113.08 |